AP
AMED

AHL Partners’s Amedisys AMED Stock Holding History

AHL Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$5.79M Sell
109,921
-101
-0.1% -$5.32K 0.09% 435
2017
Q3 		$6.16M Buy
110,022
+62,028
+129% +$3.28M 0.11% 330
2017
Q2 		$3.01M Buy
47,994
+36,934
+334% +$2.15M 0.06% 518
2017
Q1 		$565K Buy
+11,060
New +$527K 0.01% 934
2016
Q4 		– Sell
-46,893
Closed -$2.22M – 1039
2016
Q3 		$2.22M Sell
46,893
-31,120
-40% -$1.55M 0.08% 349
2016
Q2 		$3.94M Buy
+78,013
New +$3.94M 0.21% 106

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AHL Partners's AMED Position: Q4 2017 in Review

AHL Partners reduced its Amedisys (AMED) stake by 0.09% in Q4 2017, selling an estimated $5.32K and leaving 109,921 shares worth $5.79M. The position accounts for 0.09% of the portfolio, ranked #435.

AHL Partners first reported a position in AMED in Q2 2016 and has held it in 6 quarters since. The position peaked at $6.16M in Q3 2017. 188 funds tracked by Wall St. Rank hold AMED as of Q4 2017.

  • AHL Partners held 109,921 shares of Amedisys worth $5.79M as of Q4 2017.
  • AHL Partners sold 101 Amedisys shares in Q4 2017, an estimated $5.32K.
  • Amedisys made up 0.09% of AHL Partners's portfolio in Q4 2017, its #435 holding.
  • AHL Partners first reported a position in Amedisys in Q2 2016 and has held it in 6 quarters since.
  • AHL Partners's Amedisys position peaked at $6.16M in Q3 2017.
  • 188 funds tracked by Wall St. Rank held Amedisys as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.